{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:32:57Z","timestamp":1778841177093,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002871","name":"Chubu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bbrc.2020.02.165","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T01:26:58Z","timestamp":1584149218000},"page":"1074-1080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells"],"prefix":"10.1016","volume":"525","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1114-999X","authenticated-orcid":false,"given":"Chisato","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayaka","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Kawamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6067-6382","authenticated-orcid":false,"given":"Fumihiko","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0682-5006","authenticated-orcid":false,"given":"Motoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Nozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahsi","family":"Murate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.02.165_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.02.165_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ddtec.2014.03.003","article-title":"Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia","volume":"11","author":"Balabanov","year":"2014","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.bbrc.2020.02.165_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.leukres.2013.09.011","article-title":"Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia","volume":"38","author":"Soverini","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2020.02.165_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1306494","article-title":"A\u00a0phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias","volume":"369","author":"Cortes","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.02.165_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.blre.2014.06.001","article-title":"Practical issues surrounding the explosion of tyrosine kinase inhibitors for the management of chronic myeloid leukemia","volume":"28","author":"Mathisen","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbrc.2020.02.165_bib6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2009-01-199307","article-title":"KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR\/ABL translocation","volume":"114","author":"Shiotsu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.02.165_bib7","first-page":"341","article-title":"Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2","volume":"9","author":"Abe","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2020.02.165_bib8","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","article-title":"Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway","volume":"16","author":"Skorski","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2020.02.165_bib9","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1074\/jbc.M111.334532","article-title":"Discovery of marinopyrrole A (maritoclax) as a selective Mcl-1 antagonist that overcomes ABT-737 resistance by binding to and targeting Mcl-1 for proteasomal degradation","volume":"287","author":"Doi","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.02.165_bib10","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1038\/s41467-018-07551-w","article-title":"Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia","volume":"9","author":"Tron","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2020.02.165_bib11","first-page":"69","article-title":"BCL2 inhibitor ABT-199 and JNK inhibitor SP600125 exhibit synergistic cytotoxicity against imatinib-resistant Ph+ ALL cells","volume":"15","author":"Inoue","year":"2018","journal-title":"Biochem Biophys Rep"},{"key":"10.1016\/j.bbrc.2020.02.165_bib12","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10495-008-0184-y","article-title":"Bid truncation mediated by caspases-3 and -9 in vinorelbine-induced apoptosis","volume":"13","author":"Hayakawa","year":"2008","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbrc.2020.02.165_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell. Signal."},{"issue":"Pt 2","key":"10.1016\/j.bbrc.2020.02.165_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/bj3420287","article-title":"Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of five sites of phosphorylation in\u00a0vivo","volume":"342","author":"Casamayor","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2020.02.165_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2009.05.039","article-title":"SnapShot: F box proteins II","volume":"137","author":"Skaar","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2020.02.165_bib16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1038\/sj.leu.2403898","article-title":"Compensatory PI3-kinase\/Akt\/mTor activation regulates imatinib resistance development","volume":"19","author":"Burchert","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2020.02.165_bib17","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.4161\/cc.8.24.10111","article-title":"Regulation of protein stability by GSK3 mediated phosphorylation","volume":"8","author":"Xu","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2020.02.165_bib18","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fonc.2016.00078","article-title":"Protein phosphatase 2A as a therapeutic target in acute myeloid leukemia","volume":"6","author":"Arriazu","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.bbrc.2020.02.165_bib19","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/onc.2009.7","article-title":"Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients","volume":"28","author":"Samanta","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2020.02.165_bib20","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1074\/jbc.M210028200","article-title":"The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation","volume":"278","author":"Zhang","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.02.165_bib21","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-018-0803-3","article-title":"PTEN\/PTENP1: \u2019Regulating the regulator of RTK-dependent PI3K\/Akt signalling\u2019, new targets for cancer therapy","volume":"17","author":"Haddadi","year":"2018","journal-title":"Mol. Canc."},{"key":"10.1016\/j.bbrc.2020.02.165_bib22","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1111\/febs.14617","article-title":"Targeted therapies don\u2019t work for a reason; the neglected tumor suppressor phosphatase PP2A strikes back","volume":"285","author":"Westermarck","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2020.02.165_bib23","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/sj.leu.2403111","article-title":"The phosphoinositide 3-kinase\/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression","volume":"17","author":"Cappellini","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2020.02.165_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aak9982","article-title":"Degrons in cancer","volume":"10","author":"Meszaros","year":"2017","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbrc.2020.02.165_bib25","first-page":"8253","article-title":"TRIM59 induces epithelial-to-mesenchymal transition and promotes migration and invasion by PI3K\/AKT signaling pathway in medulloblastoma","volume":"15","author":"Gao","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bbrc.2020.02.165_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2020.02.165_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Cross","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2020.02.165_bib28","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/gast.2001.24044","article-title":"Inhibition of the phosphatidylinositol 3-kinase pathway contributes to HT29 and Caco-2 intestinal cell differentiation","volume":"120","author":"Wang","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2020.02.165_bib29","doi-asserted-by":"crossref","first-page":"19929","DOI":"10.1074\/jbc.273.32.19929","article-title":"Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase\/Akt cell survival pathway","volume":"273","author":"Pap","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.02.165_bib30","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1159\/000475438","article-title":"Degradation of Mcl-1 through GSK-3beta activation regulates apoptosis induced by Bufalin in Non-small cell lung cancer H1975 cells, cellular physiology and biochemistry","volume":"41","author":"Kang","year":"2017","journal-title":"Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"10.1016\/j.bbrc.2020.02.165_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079478","article-title":"Inhibition of the PI3K\/Akt\/GSK3 pathway downstream of BCR\/ABL, Jak2-V617F, or FLT3-ITD downregulates DNA damage-induced Chk1 activation as well as G2\/M arrest and prominently enhances induction of apoptosis","volume":"8","author":"Kurosu","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.02.165_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/leu.2012.180","article-title":"Downregulation of Mcl-1 through GSK-3beta activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells","volume":"27","author":"Wang","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2020.02.165_bib33","doi-asserted-by":"crossref","first-page":"16078","DOI":"10.1038\/ncomms16078","article-title":"Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy","volume":"8","author":"Inoue-Yamauchi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2020.02.165_bib34","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1182\/blood-2011-04-347849","article-title":"Bcl-xL-inhibitory BH3 mimetics can induce a transient thrombocytopathy that undermines the hemostatic function of platelets","volume":"118","author":"Schoenwaelder","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2020.02.165_bib35","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1158\/2159-8290.CD-18-0140","article-title":"A\u00a0novel MCL1 inhibitor combined with venetoclax rescues venetoclax-resistant acute myelogenous leukemia","volume":"8","author":"Ramsey","year":"2018","journal-title":"Canc. Discov."},{"key":"10.1016\/j.bbrc.2020.02.165_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.525","article-title":"MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K\/AKT\/mTOR activation in lymphoid malignancies","volume":"6","author":"Choudhary","year":"2015","journal-title":"Cell Death Dis."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20304733?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20304733?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:48:26Z","timestamp":1757764106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20304733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0006291X20304733"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.165","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of MCL1, c-myc, and cyclin D2 protein degradation in ponatinib-induced cytotoxicity against T315I(+) Ph+leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.02.165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}